The FDA has authorized Abbott to market the BinaxNOW COVID-19 Ag CARD, a kit for the rapid diagnosis of Covid-19 through a nasal swab, for emergency use (EUA).
The FDA has authorized Abbott to market the BinaxNOW COVID-19 Ag CARD, a kit for the rapid diagnosis of Covid-19 through a nasal swab, for emergency use (EUA).